Unknown

Dataset Information

0

Discovery of [1,2,4]Triazole Derivatives as New Metallo-?-Lactamase Inhibitors.

ABSTRACT: The emergence and spread of metallo-?-lactamase (MBL)-mediated resistance to ?-lactam antibacterials has already threatened the global public health. A clinically useful MBL inhibitor that can reverse ?-lactam resistance has not been established yet. We here report a series of [1,2,4]triazole derivatives and analogs, which displayed inhibition to the clinically relevant subclass B1 (Verona integron-encoded MBL-2) VIM-2. 3-(4-Bromophenyl)-6,7-dihydro-5H-[1,2,4]triazolo [3,4-b][1,3]thiazine (5l) manifested the most potent inhibition with an IC50 (half-maximal inhibitory concentration) value of 38.36 ?M. Investigations of 5l against other B1 MBLs and the serine ?-lactamases (SBLs) revealed the selectivity to VIM-2. Molecular docking analyses suggested that 5l bound to the VIM-2 active site via the triazole involving zinc coordination and made hydrophobic interactions with the residues Phe61 and Tyr67 on the flexible L1 loop. This work provided new triazole-based MBL inhibitors and may aid efforts to develop new types of inhibitors combating MBL-mediated resistance.

SUBMITTER: Yuan C 

PROVIDER: S-EPMC6982996 | biostudies-literature | 2019 Dec

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Discovery of [1,2,4]Triazole Derivatives as New Metallo-β-Lactamase Inhibitors.

Yuan Chen C   Yan Jie J   Song Chen C   Yang Fan F   Li Chao C   Wang Cheng C   Su Huiling H   Chen Wei W   Wang Lijiao L   Wang Zhouyu Z   Qian Shan S   Yang Lingling L  

Molecules (Basel, Switzerland) 20191223 1

The emergence and spread of metallo-β-lactamase (MBL)-mediated resistance to β-lactam antibacterials has already threatened the global public health. A clinically useful MBL inhibitor that can reverse β-lactam resistance has not been established yet. We here report a series of [1,2,4]triazole derivatives and analogs, which displayed inhibition to the clinically relevant subclass B1 (Verona integron-encoded MBL-2) VIM-2. 3-(4-Bromophenyl)-6,7-dihydro-5<i>H</i>-[1,2,4]triazolo [3,4-<i>b</i>][1,3]t  ...[more]

Similar Datasets

Unknown Dipicolinic Acid Derivatives as Inhibitors of New Delhi Metallo-β-lactamase-1.
| S-EPMC5599375 | biostudies-literature
Unknown Discovery of mercaptopropanamide-substituted aryl tetrazoles as new broad-spectrum metallo-β-lactamase inhibitors.
| S-EPMC9056430 | biostudies-literature
Unknown Discovery of thiosemicarbazone derivatives as effective New Delhi metallo-<i>β</i>-lactamase-1 (NDM-1) inhibitors against NDM-1 producing clinical isolates.
| S-EPMC7838035 | biostudies-literature
Unknown Discovery of potential inhibitors against New Delhi metallo-β-lactamase-1 from natural compounds: in silico-based methods.
| S-EPMC7841178 | biostudies-literature
Unknown 4-(N-Alkyl- and -Acyl-amino)-1,2,4-triazole-3-thione Analogs as Metallo-β-Lactamase Inhibitors: Impact of 4-Linker on Potency and Spectrum of Inhibition.
| S-EPMC7465886 | biostudies-literature
Unknown Computationally designed peptide macrocycle inhibitors of New Delhi metallo-β-lactamase 1.
| S-EPMC8000195 | biostudies-literature
Unknown NH-1,2,3-Triazole-based Inhibitors of the VIM-2 Metallo-β-Lactamase: Synthesis and Structure-Activity Studies.
| S-EPMC2901175 | biostudies-literature
Unknown Oligopeptides as full-length New Delhi metallo-β-lactamase-1 (NDM-1) inhibitors.
| S-EPMC5441612 | biostudies-literature
Unknown Emergence of New Delhi metallo-β-lactamase, Austria.
| S-EPMC3204651 | biostudies-literature
Unknown Structure-Based Virtual Screening for the Discovery of Novel Inhibitors of New Delhi Metallo-?-lactamase-1.
| S-EPMC5767890 | biostudies-literature